$A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance$

A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance

Pappo, Alberto S.; Vassal, Gilles; Crowley, John J.; Bolejack, Vanessa; Hogendoorn, Pancras C. W.; Chugh, Rashmi; Ladanyi, Marc; Grippo, Joseph F.; Dall, Georgina; Staddon, Arthur P.; Chawla, Sant P.; Maki, Robert G.; Araujo, Dejka M.; Geoerger, Birgit; Ganjoo, Kristen; Marina, Neyssa; Blay, Jean-Yves; Schuetze, Scott M.; Chow, Warren A.; Helman, Lee J.

期刊名称Cancer
作者Pappo, Alberto S.; Vassal, Gilles; Crowley, John J.; Bolejack, Vanessa; Hogendoorn, Pancras C. W.; Chugh, Rashmi; Ladanyi, Marc; Grippo, Joseph F.; Dall, Georgina; Staddon, Arthur P.; Chawla, Sant P.; Maki, Robert G.; Araujo, Dejka M.; Geoerger, Birgit; Ganjoo, Kristen; Marina, Neyssa; Blay, Jean-Yves; Schuetze, Scott M.; Chow, Warren A.; Helman, Lee J.
卷第120卷
期第16期
印刷ISSN0008-543X
文件大小372.32KB
发表时间2014-08-15
DOI10.1002/cncr.28728
页码2448-2456

发现好书期刊，享受阅读乐趣

A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance